SCHEMBL4562218

SCHEMBL4562218

Cn1nnc(-c2ccccn2)c1COc1ccc(Cl)cn1

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.42
GABRA5 P31644 11/20 0.39
RXRA P19793 3/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2B Q13224 3/20 0.37
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687727 0.85 GRM5 (0.42) GRM5GABRA5FLT3
SCHEMBL2687571 0.82 GABRA5 (0.59) GABRA5
SCHEMBL16104531 0.79 GABRA5 (0.52) GABRA5
SCHEMBL6370913 0.78 GABRA5 (0.49) GABRA5
SCHEMBL2689121 0.77 GABRA5 (0.45) GRM5GABRA5
SCHEMBL2687932 0.77 GABRA5 (0.63) GABRA5
SCHEMBL4562049 0.77 GRM5 (0.40) GRM5GABRA5RXRAGRIN1GRIN2B
SCHEMBL2688362 0.76 ITGA5 (0.42) GRM5GABRA5
SCHEMBL2688688 0.75 GABRA5 (0.51) GABRA5
SCHEMBL2688997 0.73 GABRA5 (0.51) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638029-A1 TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2013-09-18 EP disclosed
WO-2012062687-A1 TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2012-05-18 WO disclosed